| 依达拉奉对急性脑梗死患者高敏C反应蛋白及预后的影响 |
| |
| 引用本文： | 李克波,余颖,马振亮. 依达拉奉对急性脑梗死患者高敏C反应蛋白及预后的影响[J]. 医学综述, 2011, 17(16): 2520-2522 |
| |
| 作者姓名： | 李克波 余颖 马振亮 |
| |
| 作者单位： | 青岛市第三人民医院神经内科,山东,青岛266041 |
| |
| 摘 要： | 目的探讨依达拉奉对急性脑梗死(ACI)患者高敏C反应蛋白(hsCRP)含量及预后影响。方法选择ACI患者72例,随机分为治疗组与对照组各36例,在常规治疗的基础上,治疗组予依达拉奉30 mg静脉滴注,每日2次;对照组予奥拉西坦4.0 g静脉滴注,每日1次,疗程7 d。检测血清hsCRP、神经功能缺损和日常生活能力。结果治疗组在治疗后第7、14天hsCRP水平明显低于对照组(P<0.05);第7、14天欧洲脑卒中评分量表评分高于对照组,第7、14、30、90天日常生活活动量表评分均高于对照组(P<0.05)。结论依达拉奉可明显减轻ACI患者炎性反应,改善缺损神经功能和日常生活能力。
|
| 关 键 词： | 依达拉奉 高敏C反应蛋白 急性脑梗死 |
Effect of Edaravone on High Sensitivity C-reactive Protein and Prognosis in Patients with Acute Cerebral Infarction |
| |
| LI Ke-bo,YU Ying,MA Zhen-liang. Effect of Edaravone on High Sensitivity C-reactive Protein and Prognosis in Patients with Acute Cerebral Infarction[J]. Medical Recapitulate, 2011, 17(16): 2520-2522 |
| |
| Authors: | LI Ke-bo YU Ying MA Zhen-liang |
| |
| Affiliation: | .(Department of Neurology,Third People′s Hospital of Qingdao City,Qingdao 266041,China) |
| |
| Abstract: | Objective To observe the clinical effects of edaravone on high sensitivity C-reactive protein(hsCRP)and prognosis in patients with acute cerebral infarction(ACI).Methods 72 patients with ACI were randomly divided into study group and control group(n=36),on the basis of conventional treatment,study group were treated with edaravone of 30 mg intravenously(twice a day),control group were treated with oxiracetam of 4.0 g intravenously(once a day)respectively.All treated for 7 days.The level of serum hsCRP was m... |
| |
| Keywords: | Edaravone High sensitivity C-reactive protein Acute cerebral infarction |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
